John D. Fowler Jr.
Director · Emergent BioSolutions Inc.
- 2026
- May 4, 2026
- 2
Summary
Latest filing:
John D. Fowler Jr. is Director of Emergent BioSolutions Inc. (EBS). 2 SEC Form 4 filings on record, most recently on 4 May 2026.
Recent transactions
2The latest 2 SEC Form 4 transactions reported by John D. Fowler Jr..
Trading pattern
InsiderAlpha's records for John D. Fowler Jr. go back to 2026: 2 primary Form 4 filings, an average of 2.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies John D. Fowler Jr. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Donald W. Degolyer - $444K in EBS purchases and sales in the last 12 months
- Sujata Tyagi Dayal - $201K in EBS purchases and sales in the last 12 months
- Kathryn C. Zoon - $144K in EBS purchases and sales in the last 12 months
- Keith Katkin - $128K in EBS purchases and sales in the last 12 months
- Paul Anthony Williams - $79K in EBS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John D. Fowler Jr.?
John D. Fowler Jr. is a corporate insider, tracked as Director of Emergent BioSolutions Inc. (EBS). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did John D. Fowler Jr. last file a Form 4?
The most recent primary Form 4 on record is dated 4 May 2026, one of 2 filings going back to 2026.